Myriad Genetics Inc (MYGN)

Capital Expenditure

-$16.30M

TTM · Period ending: · USD

MYGN logo

MYGN Capital Expenditure

Latest reported-$16.30M
MYGN TTM CapEx (-$5.80M → -$16.30M)
High-resolution chart · PNG

MYGN capital expenditure history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Myriad Genetics Inc Capital Expenditure — Trailing twelve months (TTM) (USD)
Period endingCapital Expenditure (USD)
-16,300,000
-21,100,000
-21,000,000
-20,900,000
-21,600,000
-19,900,000
-23,200,000
-30,800,000
-44,800,000
-58,400,000
-73,300,000
-74,400,000
-74,600,000
-62,500,000
-45,300,000
-34,100,000
-19,400,000
-17,200,000
-18,000,000
-20,900,000
-19,400,000
-17,300,000
-13,200,000
-10,300,000
-10,200,000
-9,200,000
-9,300,000
-8,700,000
-8,600,000
-9,000,000
-8,800,000
-8,100,000
-8,400,000
-7,300,000
-5,900,000
-6,200,000
-6,100,000
-7,600,000
-6,800,000
-5,500,000
-5,000,000
-4,795,000
-8,495,000
-13,395,000
-23,895,000
-26,518,000
-23,673,000
-20,506,000
-14,271,000
-12,444,000
-12,463,000
-14,177,000
-11,373,000
-10,674,000
-11,100,000
-10,410,000
-10,058,000
-10,476,000
-10,234,000
-7,442,000
-7,292,000
-4,782,000
-4,272,000
-7,550,000
-7,168,000
-7,168,000
-5,920,000
-4,152,000
-3,509,000
-7,415,000
-9,028,000
-11,327,000
-13,675,000
-12,511,000
-12,291,000
-12,202,000
-11,400,000
-10,492,000
-11,693,000
-9,246,000
-7,680,000
-10,140,000
-8,262,000
-6,841,000
-6,736,000
-3,449,000
-3,080,000
-3,249,000
-3,883,000
-4,525,000
-5,088,000
-6,459,000
-8,036,000
-10,622,254
-10,432,169
-9,097,742
-6,852,742
-3,847,787
-4,535,454
-4,649,063
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.